NHS Cancer Waiting Times Hit Five-Year High

More than 300,000 patients in England are currently waiting beyond the NHS's 62-day target to begin cancer treatment following an urgent referral — the highest figure recorded in five years, according to NHS England performance data. The figures, published this month, reveal a deepening crisis in cancer care that persists despite government investment in new diagnostic and treatment centres across the country.

The 62-day standard, which requires patients to begin treatment within two months of an urgent GP referral, is being met for fewer than seven in ten patients — well below the NHS operational standard of 85 per cent. Campaigners and clinicians have warned that prolonged waiting times are directly linked to poorer survival outcomes, with delays at every stage of the diagnostic pathway compounding the problem.

This is not the first time the system has come under such pressure. Readers may recall earlier reporting on NHS cancer waiting times hitting a record high, and separate coverage of how NHS cancer waiting times hit an 18-month high during previous reporting periods. The current figures, however, represent a deterioration beyond those earlier benchmarks.

What the Latest Data Show

NHS England's most recent monthly statistical release shows that the proportion of patients starting cancer treatment within 62 days of urgent referral has fallen to levels not seen since before the pandemic disruptions of the early part of this decade. The absolute number of patients breaching the standard has risen sharply, driven by a combination of increased referral volumes, diagnostic workforce shortages, and ongoing capacity constraints in radiotherapy and surgical units.

Referral Volumes at Record Levels

Urgent suspected cancer referrals — so-called two-week-wait referrals — are currently running at approximately 250,000 per month in England, a figure NHS England describes as "record high demand." While increased referral rates partly reflect improved awareness and a more proactive approach by GPs, they have outpaced the system's diagnostic capacity, creating bottlenecks at endoscopy, imaging, and pathology services.

NHS officials said that while the rise in referrals is broadly positive in terms of earlier cancer identification, the infrastructure to process that demand has not kept pace. Radiology departments in particular are under significant strain, with the Royal College of Radiologists reporting a shortfall of more than 1,900 consultant radiologists in England. (Source: Royal College of Radiologists)

The Diagnostic Backlog

A significant proportion of waiting time breaches occur not during treatment itself, but at the diagnostic stage. Patients can wait weeks for an MRI, CT scan, or endoscopy before a cancer diagnosis is confirmed, and each of those delays contributes to the overall 62-day breach figure. According to NHS England performance data, the median wait from referral to first diagnostic test has lengthened considerably over the past year.

New Treatment Centres: Investment Without Immediate Impact

The government has in recent years committed to expanding the network of Community Diagnostic Centres (CDCs) across England, with more than 160 sites now operational or in development. These facilities are designed to separate routine diagnostic activity from acute hospital settings, thereby reducing pressure on main hospital sites and accelerating test turnaround times.

Why Capacity Expansion Has Not Yet Closed the Gap

Health economists and NHS analysts note that new buildings and equipment do not translate immediately into reduced waiting times. CDCs require trained staff — radiographers, sonographers, and biomedical scientists — who are in short supply nationally. NHS Providers, the membership organisation for NHS trusts, has stated that workforce gaps remain the primary constraint on expanding diagnostic throughput. (Source: NHS Providers)

Furthermore, some CDCs are not yet operating at full capacity due to ongoing construction, commissioning delays, or difficulties recruiting qualified staff. NHS England officials acknowledged in recent published guidance that the full benefits of the CDC programme will take time to materialise in waiting time statistics.

Cancer Types Most Affected

Performance data broken down by tumour type reveal that certain cancers are disproportionately affected by waiting time pressures. Lower gastrointestinal cancers — including bowel cancer — consistently show among the worst performance against the 62-day standard, partly because the diagnostic pathway involves endoscopy, which faces its own severe backlog. Lung cancer and gynaecological cancers are also cited in NHS England reports as areas of concern.

Lung Cancer: A Particular Concern

Lung cancer remains the leading cause of cancer death in the United Kingdom, and its outcomes are acutely sensitive to diagnostic speed. The majority of lung cancer patients are currently diagnosed at stage three or four, when treatment options are more limited and survival rates substantially lower. NHS England's Targeted Lung Health Check programme, which aims to identify high-risk individuals through mobile scanning units, has shown promising early results in detecting cancer at earlier stages, but coverage remains geographically uneven. (Source: NHS England)

Research published in the BMJ has demonstrated that stage at diagnosis is the most significant determinant of cancer survival, reinforcing why delayed diagnosis translates directly into avoidable mortality. (Source: BMJ)

Workforce and Systemic Pressures

The cancer waiting times crisis cannot be separated from broader NHS workforce challenges. Separately, ZenNewsUK has reported on how NHS waiting times have risen as GP shortages worsen, a trend that intersects directly with cancer care: GPs are the primary gateway for urgent cancer referrals, and understaffed practices may face delays in identifying and referring symptomatic patients in the first place. Related reporting has also examined how NHS waiting times have been driven upward by staff shortages across the service more broadly.

Oncology Staffing Shortfalls

NHS England's Long Term Workforce Plan, published previously, acknowledged a significant gap in clinical oncology and medical oncology consultant numbers. The plan projects that training pipelines will need to expand substantially to meet demand over the next decade. However, training a consultant oncologist takes a minimum of eight years from graduation, meaning that workforce expansions initiated now will not significantly alter near-term capacity. (Source: NHS England)

The WHO has consistently identified health workforce investment as the most critical lever for improving cancer outcomes globally, noting that high-income countries with strong specialist oncology workforces achieve substantially better five-year survival rates across most cancer types. (Source: WHO)

What Patients Should Know: Recognising Symptoms and Acting Promptly

Public health experts emphasise that while systemic pressures are real, patients can improve their own outcomes by seeking medical attention promptly when symptoms arise. Cancer Research UK and NICE both highlight the importance of not delaying a GP appointment if any of the following are present. (Sources: Cancer Research UK, NICE)

• Unexplained weight loss over a short period
• A lump or swelling anywhere on the body that is new or changing
• Persistent, unexplained fatigue that does not resolve with rest
• Blood in urine, stools, or when coughing
• A cough or hoarseness that has lasted more than three weeks
• Difficulty swallowing or persistent indigestion
• A mole that changes shape, size, or colour, or bleeds
• Unexplained pain that persists for more than four weeks
• Changes in bowel or bladder habits without a clear cause
• Any breast change, including nipple discharge, skin dimpling, or a new lump

Patients are advised to contact their GP if any of these symptoms persist or are unexplained. NHS guidance makes clear that urgent referrals will be made when clinical criteria are met, and patients should not delay seeking assessment out of concern about placing pressure on the health service. (Source: NHS England)

Political and Policy Response

Health ministers have acknowledged the waiting times figures and have pointed to the CDC programme, the NHS Cancer Plan under development, and recent recruitment initiatives as evidence of government commitment to improving performance. Opposition politicians have argued that the pace of improvement is insufficient given the scale of harm being caused by delays, and have called for emergency investment in diagnostic staffing.

NHS England's national cancer director has stated publicly that closing the performance gap will require "sustained effort across the whole diagnostic and treatment pathway," and has identified endoscopy, radiology, and pathology as the three areas most in need of targeted investment. (Source: NHS England)

NHS England has also signalled that it will update the NHS cancer waiting times standards framework, with a possible shift toward measuring performance at multiple points along the care pathway rather than solely at the 62-day treatment start. This methodological change has been welcomed by some clinicians as providing a more granular picture of where delays accumulate, though patient groups have urged caution that any revised metrics do not obscure the lived reality of waiting. For ongoing coverage of how these performance pressures have evolved, see earlier ZenNewsUK reporting on how NHS cancer waiting times have hit a critical level.

The trajectory of NHS cancer performance will remain under intense scrutiny in the months ahead. With referral volumes continuing to rise and workforce shortfalls expected to persist in the near term, health analysts broadly agree that the 85 per cent target for 62-day treatment is unlikely to be consistently met until structural capacity — particularly in diagnostics — is materially expanded. The evidence linking waiting times to mortality is unambiguous, and the human cost of the current backlog, measured in preventable deaths and advanced-stage diagnoses, represents one of the most pressing challenges facing the health service today.